biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a15f-01a-11d-a10y-09
biospecimen_aliquot__bcr_aliquot_uuid	33edf937-b09f-49ec-8f4c-e05dee7ece1f
biospecimen_aliquot__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100490250
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-01-12
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	11
biospecimen_aliquot__plate_id	a10y
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.86
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a15f-01a-11d
biospecimen_analyte__bcr_analyte_uuid	41417b65-afa6-42e3-b1c9-427a39aed8e2
biospecimen_analyte__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a15f
biospecimen_diagnostic_slides__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	f022214a-3f0c-4da4-a0ee-735d27480a45
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a15f
biospecimen_normal_control__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_normal_control__ncedna_dna_conc	0.286
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	70
biospecimen_normal_control__normal_tissue_anatomic_site	other
biospecimen_portion__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_portion__bcr_portion_barcode	tcga-e2-a15f-01a-11
biospecimen_portion__bcr_portion_uuid	48fb97df-469d-40a5-b760-7b15b6726a57
biospecimen_portion__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_portion__date_of_creation	2010-12-22
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a15f-01a-11d
biospecimen_protocol__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_sample__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_sample__bcr_sample_uuid	996911f9-c9fe-48d8-aa35-5672610e72fb
biospecimen_sample__days_to_collection	360
biospecimen_sample__initial_weight	190
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a15f.19360b66-c514-4ee1-acd7-08873828133e.pdf
biospecimen_sample__pathology_report_uuid	19360b66-c514-4ee1-acd7-08873828133e
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	3d2f1976-cf0a-4cab-817a-92301b6d9275
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a15f-01a-21-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
biospecimen_slide__bcr_sample_barcode	tcga-e2-a15f-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a15f-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	ec2c2158-f027-40b9-945e-e081c7b80e46
biospecimen_slide__image_file_name	tcga-e2-a15f-01a-01-ts1.ec2c2158-f027-40b9-945e-e081c7b80e46.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	2
biospecimen_slide__percent_stromal_cells	27
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a15f
biospecimen_tumor_sample__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
clinical_drug__bcr_drug_barcode	tcga-e2-a15f-d18907
clinical_drug__bcr_drug_uuid	1eac6d1e-0e8f-4ad2-8571-21809ff6f41c
clinical_drug__bcr_patient_barcode	tcga-e2-a15f
clinical_drug__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
clinical_drug__form_completion_date	2011-11-10
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	87
clinical_drug__pharmaceutical_tx_total_dose_units	mg/day
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	1
clinical_follow_up__bcr_followup_barcode	tcga-e2-a15f-f18906
clinical_follow_up__bcr_followup_uuid	b97a662c-1e3b-4e86-a42a-e23819047d85
clinical_follow_up__bcr_patient_barcode	tcga-e2-a15f
clinical_follow_up__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-11-10
clinical_follow_up__last_contact_days_to	658
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	64
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage i
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a15f
clinical_patient__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
clinical_patient__birth_days_to	-23660
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-13
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	469
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	3
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a15f
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	90-99%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a15f
clinical_radiation__bcr_patient_uuid	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db
clinical_radiation__bcr_radiation_barcode	tcga-e2-a15f-r18908
clinical_radiation__bcr_radiation_uuid	d9e37765-4428-4c8e-a7d0-6c851a7c95ff
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-11-10
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	86
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	42
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A15F-01A-11D-A10Y-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A15F-01A-11D-A10Y-09.bed.meta
manually_curated__id	tcga-e2-a15f-01a-11d-a10y-09
manually_curated__md5sum	72e62f5d50814a83ee09a97a42fc6025
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	33edf937-b09f-49ec-8f4c-e05dee7ece1f
manually_curated__tumor_tag	brca
